Boehringer Ingelheim Venture Fund
Ingelheim am Rhein, GermanyFounded 2010
The Boehringer Ingelheim Venture Fund (BIVF) is the corporate venture capital arm of Boehringer Ingelheim, investing in groundbreaking therapeutics-focused biotechnology companies to drive innovation in biomedical research across immuno-oncology, regenerative medicine, and infectious diseases.
39% of their portfolio is in Biotech & Life Sciences. Deal activity decreased year-over-year (2 deals in the last 12 months vs 4 prior). Average disclosed round size is $25.6M (across 16 rounds with reported amounts).
Portfolio
46
Fund Size
—
Top Stage
Series A
Last 12 Mo
2
Team
Kevin White
Investment Manager
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
57 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 Centauri Therapeutics | Series A | — | Feb 2026 |
 STRM.BIO | Seed | $8M | Jan 2026 |
 Brainomix | Series C | $18M | Mar 2025 |
| RRefoxy Pharmaceuticals | Seed | $10M | Dec 2024 |
 Glox Therapeutics | Unknown | — | Nov 2024 |
 AIgnostics | Series B | $34M | Oct 2024 |
 Asgard Therapeutics | Series A | — | Mar 2024 |
 ILARA HEALTH | Seed | $4.2M | Feb 2024 |
 HepaRegenix | Series C | — | Jan 2024 |
 Refoxy Pharma | Seed | — | Jan 2024 |
 Obulytix | Seed | — | Dec 2023 |
| Glox Therapeutics | Seed | — | Nov 2023 |
 Otto | Series B | $43M | Aug 2023 |
 C Mo Medical Solutions | Unknown | — | Jan 2023 |
 DiogenX | Series A | — | Jan 2023 |
| RRgenta | Series A | $52M | Nov 2022 |
| AIgnostics | Series A | — | Sep 2022 |
 ImCheck | Series C | — | Jun 2022 |
| C Mo Medical Solutions | Seed | — | Jan 2022 |
 Optina Diagnostics | Series A | — | Oct 2021 |
 Topas Therapeutics | Series B | — | Jul 2021 |
| RRinri Therapeutics | Unknown | $13.8M | Apr 2021 |
 Agomab Therapeutics | Series B | $74M | Mar 2021 |
 xCures | Series A | $12.7M | Jan 2021 |
 Libra Therapeutics | Series A | $29M | Sep 2020 |
Page 1 of 3
Top Co-Investors
High-Tech Gründerfonds22 shared
Wellington Management5 shared
Gimv5 shared
Vi Partners5 shared
Andera Partners4 shared
Kurma Partners4 shared
coparion4 shared
Omnes Capital3 shared
EQT Life Sciences3 shared
Pfizer Ventures3 shared
Idinvest Partners3 shared
NRW.BANK3 shared
Epidarex Capital3 shared
Portugal Ventures3 shared
Apollo Health Ventures3 shared
Carma Fund2 shared
Versant Ventures2 shared
Delos Capital2 shared
Novo Holdings A/S2 shared
Pontifax2 shared
Last updated: 8 September 2026